Cargando…

Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy

With hollow mesoporous silica (hMSN) and injectable macroporous hydrogel (Gel) used as the internal and external drug-loading material respectively, a sequential drug delivery system DOX-CA4P@Gel was constructed, in which combretastatin A4 phosphate (CA4P) and doxorubicin (DOX) were both loaded. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Yuanyuan, Zhang, Li, Sun, Shian, Zhou, Zhenghao, Ma, Yunsu, Hong, Hao, Yang, Dongzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542336/
https://www.ncbi.nlm.nih.gov/pubmed/34688292
http://dx.doi.org/10.1186/s12951-021-01066-1
_version_ 1784589409633435648
author Zhong, Yuanyuan
Zhang, Li
Sun, Shian
Zhou, Zhenghao
Ma, Yunsu
Hong, Hao
Yang, Dongzhi
author_facet Zhong, Yuanyuan
Zhang, Li
Sun, Shian
Zhou, Zhenghao
Ma, Yunsu
Hong, Hao
Yang, Dongzhi
author_sort Zhong, Yuanyuan
collection PubMed
description With hollow mesoporous silica (hMSN) and injectable macroporous hydrogel (Gel) used as the internal and external drug-loading material respectively, a sequential drug delivery system DOX-CA4P@Gel was constructed, in which combretastatin A4 phosphate (CA4P) and doxorubicin (DOX) were both loaded. The anti-angiogenic drug, CA4P was initially released due to the degradation of Gel, followed by the anti-cell proliferative drug, DOX, released from hMSN in tumor microenvironment. Results showed that CA4P was mainly released at the early stage. At 48 h, CA4P release reached 71.08%, while DOX was only 24.39%. At 144 h, CA4P was 78.20%, while DOX release significantly increased to 61.60%, showing an obvious sequential release behavior. Photodynamic properties of porphyrin endow hydrogel (ϕ(Δ(Gel)) = 0.91) with enhanced tumor therapy effect. In vitro and in vivo experiments showed that dual drugs treated groups have better tumor inhibition than solo drug under near infrared laser irradiation, indicating the effectivity of combined photodynamic-chemotherapy. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-021-01066-1.
format Online
Article
Text
id pubmed-8542336
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85423362021-10-25 Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy Zhong, Yuanyuan Zhang, Li Sun, Shian Zhou, Zhenghao Ma, Yunsu Hong, Hao Yang, Dongzhi J Nanobiotechnology Research With hollow mesoporous silica (hMSN) and injectable macroporous hydrogel (Gel) used as the internal and external drug-loading material respectively, a sequential drug delivery system DOX-CA4P@Gel was constructed, in which combretastatin A4 phosphate (CA4P) and doxorubicin (DOX) were both loaded. The anti-angiogenic drug, CA4P was initially released due to the degradation of Gel, followed by the anti-cell proliferative drug, DOX, released from hMSN in tumor microenvironment. Results showed that CA4P was mainly released at the early stage. At 48 h, CA4P release reached 71.08%, while DOX was only 24.39%. At 144 h, CA4P was 78.20%, while DOX release significantly increased to 61.60%, showing an obvious sequential release behavior. Photodynamic properties of porphyrin endow hydrogel (ϕ(Δ(Gel)) = 0.91) with enhanced tumor therapy effect. In vitro and in vivo experiments showed that dual drugs treated groups have better tumor inhibition than solo drug under near infrared laser irradiation, indicating the effectivity of combined photodynamic-chemotherapy. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-021-01066-1. BioMed Central 2021-10-23 /pmc/articles/PMC8542336/ /pubmed/34688292 http://dx.doi.org/10.1186/s12951-021-01066-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhong, Yuanyuan
Zhang, Li
Sun, Shian
Zhou, Zhenghao
Ma, Yunsu
Hong, Hao
Yang, Dongzhi
Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy
title Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy
title_full Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy
title_fullStr Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy
title_full_unstemmed Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy
title_short Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy
title_sort sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542336/
https://www.ncbi.nlm.nih.gov/pubmed/34688292
http://dx.doi.org/10.1186/s12951-021-01066-1
work_keys_str_mv AT zhongyuanyuan sequentialdrugdeliverybyinjectablemacroporoushydrogelsforcombinedphotodynamicchemotherapy
AT zhangli sequentialdrugdeliverybyinjectablemacroporoushydrogelsforcombinedphotodynamicchemotherapy
AT sunshian sequentialdrugdeliverybyinjectablemacroporoushydrogelsforcombinedphotodynamicchemotherapy
AT zhouzhenghao sequentialdrugdeliverybyinjectablemacroporoushydrogelsforcombinedphotodynamicchemotherapy
AT mayunsu sequentialdrugdeliverybyinjectablemacroporoushydrogelsforcombinedphotodynamicchemotherapy
AT honghao sequentialdrugdeliverybyinjectablemacroporoushydrogelsforcombinedphotodynamicchemotherapy
AT yangdongzhi sequentialdrugdeliverybyinjectablemacroporoushydrogelsforcombinedphotodynamicchemotherapy